Drug recall
Amoxil (trade name), Amoxicillin as Trihydrate, powder for oral suspension, 250 mg/5 mL, 150mL, Rx only…
FDA recall event 31510 · Class III · GlaxoSmithKline Inc
Key facts
| Event ID | 31510 |
|---|---|
| Recall numbers | D-190-5 |
| Recalling firm | GlaxoSmithKline Inc |
| Product type | Drugs |
| Products | Amoxil (trade name), Amoxicillin as Trihydrate, powder for oral suspension, 250 mg/5 mL, 150mL, Rx only, GlaxoSmithKline, Research Triangle Park, NC, 27709, NDC No.: 0029-6009-22 |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Mislabeling: 250mg/5mL, 150mL bottles may be mislabeled as 250mg/5mL, 100mL bottles. |
| Initiation date | Mar 29, 2005 |
| City | Durham |
| Country | United States |
| FEI number | 1035048 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports